![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: KIAA1211 |
Gene summary for KIAA1211 |
![]() |
Gene information | Species | Human | Gene symbol | KIAA1211 | Gene ID | 57482 |
Gene name | capping protein inhibiting regulator of actin dynamics | |
Gene Alias | CRAD | |
Cytomap | 4q12 | |
Gene Type | protein-coding | GO ID | GO:0001894 | UniProtAcc | Q6ZU35 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
57482 | KIAA1211 | HTA11_3410_2000001011 | Human | Colorectum | AD | 1.37e-21 | -6.33e-01 | 0.0155 |
57482 | KIAA1211 | HTA11_2487_2000001011 | Human | Colorectum | SER | 1.52e-12 | -6.33e-01 | -0.1808 |
57482 | KIAA1211 | HTA11_2951_2000001011 | Human | Colorectum | AD | 4.93e-02 | -6.33e-01 | 0.0216 |
57482 | KIAA1211 | HTA11_1938_2000001011 | Human | Colorectum | AD | 2.36e-09 | -6.33e-01 | -0.0811 |
57482 | KIAA1211 | HTA11_78_2000001011 | Human | Colorectum | AD | 6.93e-15 | -6.33e-01 | -0.1088 |
57482 | KIAA1211 | HTA11_347_2000001011 | Human | Colorectum | AD | 3.24e-23 | -6.33e-01 | -0.1954 |
57482 | KIAA1211 | HTA11_3361_2000001011 | Human | Colorectum | AD | 9.60e-10 | -6.33e-01 | -0.1207 |
57482 | KIAA1211 | HTA11_83_2000001011 | Human | Colorectum | SER | 1.22e-07 | -6.33e-01 | -0.1526 |
57482 | KIAA1211 | HTA11_696_2000001011 | Human | Colorectum | AD | 4.96e-35 | -6.33e-01 | -0.1464 |
57482 | KIAA1211 | HTA11_866_2000001011 | Human | Colorectum | AD | 3.49e-32 | -6.33e-01 | -0.1001 |
57482 | KIAA1211 | HTA11_1391_2000001011 | Human | Colorectum | AD | 2.15e-17 | -6.33e-01 | -0.059 |
57482 | KIAA1211 | HTA11_2992_2000001011 | Human | Colorectum | SER | 5.36e-03 | -6.33e-01 | -0.1706 |
57482 | KIAA1211 | HTA11_5212_2000001011 | Human | Colorectum | AD | 1.06e-03 | -6.33e-01 | -0.2061 |
57482 | KIAA1211 | HTA11_5216_2000001011 | Human | Colorectum | SER | 4.93e-02 | -6.33e-01 | -0.1462 |
57482 | KIAA1211 | HTA11_546_2000001011 | Human | Colorectum | AD | 1.74e-06 | -6.33e-01 | -0.0842 |
57482 | KIAA1211 | HTA11_7862_2000001011 | Human | Colorectum | AD | 4.57e-05 | -6.33e-01 | -0.0179 |
57482 | KIAA1211 | HTA11_866_3004761011 | Human | Colorectum | AD | 5.35e-19 | -6.33e-01 | 0.096 |
57482 | KIAA1211 | HTA11_4255_2000001011 | Human | Colorectum | SER | 4.93e-02 | -6.33e-01 | 0.0446 |
57482 | KIAA1211 | HTA11_8622_2000001021 | Human | Colorectum | SER | 4.77e-04 | -6.33e-01 | 0.0528 |
57482 | KIAA1211 | HTA11_7663_2000001011 | Human | Colorectum | SER | 1.61e-02 | -6.33e-01 | 0.0131 |
Page: 1 2 3 4 |
![]() |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | ![]() |
Colorectum | SER | ![]() |
Colorectum | MSS | ![]() |
Colorectum | MSI-H | ![]() |
Colorectum | FAP | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
Page: 1 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
Page: 1 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
KIAA1211 | SNV | Missense_Mutation | c.2237N>A | p.Arg746Gln | p.R746Q | Q6ZU35 | protein_coding | tolerated(0.12) | possibly_damaging(0.526) | TCGA-D1-A17H-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD | |
KIAA1211 | SNV | Missense_Mutation | novel | c.559G>A | p.Gly187Ser | p.G187S | Q6ZU35 | protein_coding | tolerated(0.34) | benign(0.007) | TCGA-D1-A2G0-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
KIAA1211 | SNV | Missense_Mutation | novel | c.1031N>A | p.Arg344Gln | p.R344Q | Q6ZU35 | protein_coding | tolerated(0.95) | benign(0) | TCGA-DF-A2KN-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | Unknown | I/II | Unknown | Unknown | SD |
KIAA1211 | SNV | Missense_Mutation | novel | c.418N>A | p.Val140Ile | p.V140I | Q6ZU35 | protein_coding | tolerated(0.92) | benign(0.361) | TCGA-DF-A2KU-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | Unknown | I/II | Unknown | Unknown | SD |
KIAA1211 | SNV | Missense_Mutation | c.1645N>A | p.Leu549Ile | p.L549I | Q6ZU35 | protein_coding | tolerated(0.73) | probably_damaging(0.996) | TCGA-DF-A2KU-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | Unknown | I/II | Unknown | Unknown | SD | |
KIAA1211 | SNV | Missense_Mutation | novel | c.1271N>G | p.Asn424Ser | p.N424S | Q6ZU35 | protein_coding | tolerated(0.76) | benign(0) | TCGA-DI-A1BU-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Chemotherapy | paclitaxel | SD |
KIAA1211 | SNV | Missense_Mutation | rs757082455 | c.1382N>A | p.Arg461Gln | p.R461Q | Q6ZU35 | protein_coding | tolerated(0.59) | benign(0.028) | TCGA-EO-A22R-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
KIAA1211 | SNV | Missense_Mutation | novel | c.3046N>A | p.Pro1016Thr | p.P1016T | Q6ZU35 | protein_coding | deleterious(0.04) | benign(0.155) | TCGA-EO-A22R-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
KIAA1211 | SNV | Missense_Mutation | novel | c.2467G>A | p.Glu823Lys | p.E823K | Q6ZU35 | protein_coding | tolerated(0.09) | benign(0.123) | TCGA-EO-A22U-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
KIAA1211 | SNV | Missense_Mutation | rs763160970 | c.11N>A | p.Arg4Gln | p.R4Q | Q6ZU35 | protein_coding | deleterious(0) | probably_damaging(0.999) | TCGA-EO-A3AY-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | PD |
Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
Page: 1 |